Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Laminar Medica Ltd

Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Laminar Medica Ltd
Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
+44 (0)1442 828664
Contact Laminar Medica Ltd
Website

 Latest Content from PMHub 

Pegasus Moves to Brighton

Press Releases | April 29, 2014 | Inizio

Top UK Healthcare Communications Consultancy Moves to Brighton

UX: Designing Human Experiences

White Papers and Resources | April 24, 2014 | Havas Lynx

Applying science to the creative process to improve lives

08 UX: Pushing the right buttons

White Papers and Resources | March 31, 2014 | Havas Lynx

Unlocking better outcomes in healthcare with UX

UX: Pushing the right buttons

White Papers and Resources | March 31, 2014 | Havas Lynx

Unlocking better outcomes in healthcare with UX

07 Good Pharma

White Papers and Resources | January 3, 2014 | Havas Lynx

Better for patients, better for business

06 Our Opportunity to Rethink the Health Experience

White Papers and Resources | January 3, 2014 | Havas Lynx

Our point of view

05 Social Media: A Health Hazard?

White Papers and Resources | January 3, 2014 | Havas Lynx

The case to embrace going social

Creating a Lifeline to the New Digital User

White Papers and Resources | January 3, 2014 | Havas Lynx

Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...

Warehousing of HCV patients reaches new high

White Papers and Resources | December 19, 2013 | Inizio

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Brand leaders in RA will lose market share, predict rheumatologists

White Papers and Resources | December 19, 2013 | Inizio

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.